Read More

Novo Nordisk’s Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China

Novo Nordisk warns of Ozempic starter kit scarcity in Germany amid ongoing supply challenges in Europe. Restrictions on off-label use emphasized, with intermittent shortages expected in 2024. Biosimilar Jiyoutai awaits approval in China. FDA tightens Mounjaro supply due to high demand.

LLY

Read More

FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape

FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements in treatment. Learn more about this groundbreaking development."

ABBV

Read More

Cal-Maine Foods, Inc. Reports Positive Test Result For Avian Influenza At Texas Facility, Resulting In Depopulation Of ~1.6M Laying Hens And 337,000 Pullets, Or ~3.6% Of The Company’s Total Flock As Of March 2, 2024

Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods" or "Company") today reported that one of the Company's facilities located in Parmer County, Texas, tested positive for highly pathogenic avian influenza ("HPAI"),

CALM